¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Induced disease by proxy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • occlusive cerebrovascular disease
    Æó¼â³úÇ÷°üº´, Æó¼â³úÇ÷°üÁúȯ
  • occupational dental disease
    Á÷¾÷Ä¡°úº´
  • occupational disease
    Á÷¾÷º´
  • organic disease
    ±âÁúº´
  • Osgood-Schlatter disease
    ¿À½º±Â-½¶¶óÅͺ´
  • obstructive pulmonary disease
    Æó¼âÆóº´
  • Owren¡¯s disease
    ¿Àºê·»º´
  • phytanic acid storage disease
    ÇÇź»êÃàÀûº´
  • Pick disease
    ÇȺ´
  • pigeon breeder¡¯s disease
    ºñµÑ±â»çÀ°ÀÚº´
  • pandemic disease
    ¹üÀ¯Çິ
  • pneumatic hammer disease
    ¾ÐÂø°ø±âÇØ¸Óº´
  • polycystic kidney disease
    ´Ù³¶½ÅÀ庴, ¹µÁÖ¸Ó´ÏÄáÆÏº´
  • panzootic disease
    µ¿¹°¹üÀ¯Çິ
  • posttransplant lymphoproliferative disease
    À̽ÄÈĸ²ÇÁ¼¼Æ÷Áõ½Äº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • posttransplant lymphoproliferative disease
    À̽ÄÈĸ鿪Áõ½Äº´
  • prenatal disease
    Ãâ»ýÀüº´
  • primary pigmented nodular adrenocortical disease
    ÀÏÂ÷»ö¼ÒÄ§Âø°áÁ¤ºÎ½Å°ÑÁúº´
  • professional disease
    Á÷¾÷º´
  • protozoan disease
    ¿øÃ溴
  • psychosomatic disease
    Á¤½Å½Åüº´
  • pulmonary disease
    Æóº´
  • pulseless disease
    ¹«¸Æ¹Úº´, ¹«¸Æº´
  • pyramidal disease
    ÇǶó¹Ô½Å°æ·Îº´, Ãßü½Å°æ·Îº´
  • quarantinable disease
    °Ë¿ªÁúȯ
  • rat-bite disease
    Áã¹°±âº´
  • Raynaud¡¯s disease
    ·¹À̳뺴
  • recessive hereditary disease
    ¿­¼ºÀ¯Àüº´
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
  • reported communicable disease
    ½Å°íµÈÀü¿°º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • glycogen storage disease
    ±Û¸®ÄÚ°ÕÃàÀûÁúȯ
  • graft versus host disease
    ´ë¼÷ÁÖÀÌ½ÄÆíÁúȯ
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´.
  • graft versus host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë¼÷ÁÖº´
  • graft-versus-host disease
    ÀÌ½ÄÆí´ë ¼÷ÁÖº´
  • granulomatous disease
    À°¾ÆÁ¾¼º Áúȯ.
  • granulomatous disease
    À°¾ÆÁ¾¼º Áúȯ
  • granulomatous disease of childhood
    ¼Ò¾ÆÀ°¾ÆÁ¾¼º Áúȯ.
  • granulomatous disease of childhood
    ¼Ò¾Æ À°¾ÆÁ¾¼º Áúȯ
  • graves disease
    ±×·¹À̺꽺 º´, Grave º´
  • grinder s disease ; silicosis
    ±ÔÆóÁõ, ºÐ¼â±â°øº´.
  • grinder s disease ; silicosis
    ±ÔÆóÁõ.
  • hallervoden-spatz disease
    ÇÒ·¯º¸µç-½´ÆÄÂê º´, Hallervoden-Spatz º´
  • hand and foot disease
    ¼ö Á· Áúȯ£¨â¢ðëòðü´£©£¬¼Õ ¹ß º´, ¼ö Á· º´ (â¢ðëÜ»).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
  • cystic disease of liver
    °£³¶¼ºÁúȯ(ÊÜÒ¥àõ òðü´).
  • cystic disease of liver
    ³¶¼º°£Áúȯ(³¶¼º°£Áúȯ).
  • cystic disease of lung
    È£Èí ³¶¼ºÆóÁúȯ(Ò¥àõøËòðü´).
  • cystic kidney disease
    ³¶¼º½ÅÁúȯ(Ò¥àõãìòðü´).
  • cystine disease
    ½Ã½ºÆ¾º´(¡­Ü»).
  • cystine storage disease
    ½Ã½ºÆ¾(ÃàÀû)º´ (¡­õëîÝÜ»).
  • cytomegalic inclusion disease
    ¼¼Æ÷ °Å´ë ºÀÀÔü º´
  • cytomegalic inclusion disease
    ¼¼Æ÷°Å´ëÈ­ ºÀÀÔüº´
  • cytomegalic inclusion disease =CID
    ¼¼Æ÷°Å´ë¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =CID
    ¼¼Æ÷°Å´ë¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =CID
    °Å´ë¼¼Æ÷ºÀÀÔüÁúȯ(ËÝÓÞá¬øàÜæìýô÷òðü´).
  • cytomegalic inclusion disease =cid
    °Å´ë¼¼Æ÷¼º ºÀÀÔüº´(¡­ËÝÓÞàõÜæìýô÷ Ü»), °Å´ë¼¼Æ÷ ºÀÀÔüÁúȯ(¡­òðü´)
  • degenerative brain disease
    ÅðÇ༺ ³úÁúȯ.
  • degenerative brain disease
    ÅðÇ༺ ³úÁúº´(÷Üú¼àõ ÒàòðÜ»).
  • degenerative disease
    ÅðÇ༺ Áúȯ.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
NIPTS noise-induced permanent threshold shift
OPIDN organophosphorus-induced delayed neuropathy
PIH periventricular-intraventricular hemorrhage; phenyl isopropylhydrazine; pregnancy-induced hypertensi...
PIM penicillamine-induced myasthenia
PIT pacing-induced tachycardia; patella inhibition test; picture identification test; pitocin; pitressin...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 19
NIP neuroleptic induced Parkinsonism
NIPTS noise-induced permanent threshold shift
OPIDN organophosphorous compound-induced delayed neurotoxicity
OPIDN organophosphorus induced delayed neurotoxicity
PIB propranolol induced bronchoconstriction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • spirochetal disease
    ½ºÇÇ·ÎÇìŸ Áúȯ
  • sporadic disease
    »ê¹ß Áúȯ, »ê¹ß¼º Áúȯ
  • sterility disease
    ºÒÀÓ¼º Áúȯ
  • Still's disease
    ½ºÆ¿ Áúȯ, ½ºÆ¿ º´
    µ¿ÀǾî=juvenile rheumatoid arthritis. 1. Ç÷û¿¡ ÀÌ»óÀÌ ³ªÅ¸³ªÁö ¾Ê´Â °üÀý¿°À¸·Î¼­ Á¾Á¾ ¹ß¿­°ú ¸²ÇÁÀýº´ÁõÀÌ µ¿¹ÝµÇ¸ç 16¼¼ ÀÌÀü¿¡ ½ÃÀÛÇÏ´Â °üÀý¿°ÀÇ 70%¸¦ Â÷ÁöÇÑ´Ù. 2. ¼Ò¾Æ¼º ¸²ÇÁÁ¾ ºñÁ¾¼º À§Ãà ´Ù¹ß¼º °üÀý¿°. ¼Ò¾Æ¿¡ »ý±â´Â ¸¸¼º ´Ù¹ß¼º °üÀý¿°ÀÇ ÀÏÁ¾. ¸²ÇÁÀý Á¾Ã¢, ºñÁ¾, ºÒ±ÔÄ¢¼º ¹ß¿­ÀÌ Æ¯Â¡ÀÌ´Ù.
  • storage pool disease
    ÀúÀåÁ¶º´
    ÀÀÁýÁ¦, ¿¡Çdz×ÇÁ¸°, ¿ÜÀμº ADP, Æ®·Òºó µî¿¡ ¹ÝÀÀÇÏ¿© ADP¸¦ ¹æÃâÇÏ´Â Ç÷¼ÒÆÇ ±â´É ºÎÀü¿¡ ÀÇÇÑ Ç÷¾× ÀÀ°í Àå¾Ö, °¡º­¿î ÃâÇ÷ Áõ»ó, ÃâÇ÷ ½Ã°£ Áö¿¬, ±³¿øÁúÀ̳ª Æ®·Òºó¿¡ ´ëÇÑ ÀÀÁý ¹ÝÀÀÀÇ °¨Å𸦠Ư¡À¸·Î ÇÑ´Ù.
  • stripe disease
    ¼±Á¶º´
  • strumpell's disease Ãø»è °æÈ­ÁõÀÇ À¯ÀüÇüÀ¸·Î ÀÌ Áúº´¿¡¼­ÀÇ °æ·ÃÀº ÁÖ·Î ¹ß¿¡ ÇÑÁ¤µÇ¾î ÀϾ´Ù.

    strychnine

    ½ºÆ®¸®Å©´Ñ
    ±Øµµ·Î µ¶¼ºÀÌ °­ÇÑ ¾ËÄ®·ÎÀ̵å. ÁÖ·Î Strychnos nuxvomica ¹× StrychnosÀÇ ´Ù¸¥ Á¾¿¡¼­ ¾ò¾îÁö¸ç, ½Å°æ Ãæµ¿ÀÇ Á¢ÇպΠÈĺÎÀÇ ¾ïÁ¦¸¦ Â÷´ÜÇÔÀ¸·Î½á ÁßÃß ½Å°æ°èÀÇ ¸ðµç ºÎºÐÀ» ÈïºÐ½ÃŲ´Ù. ÁßÃß ½Å°æ°èÀÇ ÈïºÐÁ¦·Î »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÀÌÀü¿¡´Â °í¹Ì °­ÀåÁ¦, ¼øÈ¯ ÀÚ±ØÁ¦·Î ¶Ç´Â ¼³»çÁ¦¿Í ¾Æ¿ï·¯ »ç¿ëµÇ¾ú´Ù.
  • subacute disease
    ¾Æ±Þ¼º Áúȯ
  • systemic degenerative joint disease
    Àü½Å¼º ÅðÇ༺ °üÀý Áúȯ
  • tay-sachs disease Èæ³»À强 °¡Á·¼º ¹éÄ¡ÀÇ ¿µ¾ÆÇü.

    tazettine

    ŸÁ¦Æ¾
  • temporomandibular joint disease
    ÃøµÎÇϾǰüÀý Áúȯ
  • Thomsen's disease : ¼±Ãµ¼º ±Ù±äÀåÁõ.

    thoracalgia

    È亮Åë
  • thromboembolic disease
    Ç÷Àü »öÀü¼º Áúȯ
  • thyrotoxic heart disease
    °©»ó¼± Áßµ¶¼º ½ÉÀ庴
    °©»ó¼± ±â´É Ç×Áø°ú °ü·ÃÇÑ ½ÉÀå ÁúȯÀ¸·Î ½É¹æ ¼¼µ¿. ½ÉÀå È®´ë, ¿ïÇ÷¼º ½ÉºÎÀü µîÀÌ ³ªÅ¸³­´Ù.
  • tropical disease
    ¿­´ëº´
    °í¿Â ´Ù½ÀÇÏ°í ¹Ì°³¹ß Áö¿ªÀÌ ¸¹Àº ¿­´ë Áö¹æ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÏ´Â º´. ´ëÇ¥ÀûÀÎ °ÍÀ¸·Î´Â ¾Æ¸Þ¹Ù Àû¸®, Ä®¶ó¾ÆÀÚ¸£
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 19
Marek's disease virus The herpesvirus that causes avian lymphomatosis (Marek's disease); is distinct from those causing other forms of leukosis.
Synonym: avian lymphomatosis virus, fowl neurolymphomatosis virus, Marek's disease virus.
(05 Mar 2000)
Marfan's disease <syndrome> A hereditary condition of the connective tissue.
Symptoms and signs include tall lean body type, irregular or unsteady gait, long extremities (including fingers and toes), abnormal joint flexibility, flat feet, stooped shoulders, dislocation of the optic lens and aneurysms of the aorta. Affects 1 in 50,000 people. Probably a collagen fibril assembly disorder since it can be mimicked in mice by aminonitriles that interfere with crosslinking.
Inheritance: autosomal dominant.
(06 Oct 1997)
margarine disease Erythema multiforme caused by an emulsifying agent used in the manufacture of margarine.
(05 Mar 2000)
genital ulcer disease Ulcerative lesions on the genitals, usually caused by a sexually transmitted condition such as herpes, syphilis or chancroid. The presence of genital ulcers may increase the risk of transmitting HIV.
(09 Oct 1997)
parasitic disease A disease due to the presence and vital activity of a parasite, or as a reaction to a parasite.
(05 Mar 2000)
parasitic eosinophilic lung disease <radiology> All are metazoans (mostly nematodes), Ascaris, Strongyloides, Ancyclostoma, Schistosoma, tropical pulmonary eosinophilia, pulmonary larva migrans
(12 Dec 1998)
Marie's disease A hypertrophic osteopathy of dogs in which osseous changes of the limbs are associated with intrathoracic lesions such as pulmonary neoplasms; also occurs in horses, cattle, and sheep.
(05 Mar 2000)
Marie-Strumpell disease <rheumatology> A polyarthritis involving the spine, which is characterised by progressive, painful stiffening of the joints and ligaments. It almost exclusively affects young men.
Interestingly the disease seems to be associated with HLA B27, those with this histocompatability antigen are 300 times more likely to get the disease, 90% of sufferers have HLA B27
(18 Nov 1997)
Marion's disease A congenital obstruction of the posterior urethra.
(05 Mar 2000)
Recklinghausen's disease of bone Rarefying osteitis with fibrous degeneration and formation of cysts, and with the presence of fibrous nodules on the affected bones. It is due to marked osteoclastic activity secondary to hyperfunction of the parathyroid glands.
(12 Dec 1998)
Recklinghausen's disease type I type 2 neurofibromatosis
Gerhardt-Mitchell disease Disease marked by paroxysmal, bilateral vasodilatation, particularly of the extremities, with burning pain, and increased skin temperature and redness.
(12 Dec 1998)
Gerhardt's disease Disease marked by paroxysmal, bilateral vasodilatation, particularly of the extremities, with burning pain, and increased skin temperature and redness.
(12 Dec 1998)
vertebral-basilar artery disease <cardiology> Aortic arch syndrome, also referred to by many as vertebral-basilar artery disease, carotid artery occlusive syndrome and subclavian steal syndrome is characterised by a constellation of signs and symptoms which occur secondary to abnormalities in the major arteries which extend off of the aortic arch.
These abnormalities are structural and most often secondary to the effects of atherosclerosis, blood clots, trauma or a congenital abnormality. Symptoms of this condition include various neurologic symptoms, reduction in pulse and changes in blood pressure.
(27 Sep 1997)
Gerlier's disease A paroxysmal attack of severe vertigo, not accompanied by deafness or tinnitus, which affects young to middle-aged adults, often following a non-specific upper respiratory infection; due to unilateral vestibular dysfunction.
Synonym: endemic paralytic vertigo, epidemic vertigo, Gerlier's disease, kubisagari, kubisagaru, paralyzing vertigo.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 19
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 19
ÅëÇÕ°Ë»ö ¿Ï·á